Effect of Natural Estrogen on the Serum Level of Follicle-Stimulating Hormone (FSH), Estradiol and Estrone in post-menopausal women and its effect on endometrium

References

• Antunes C MF, Stolley P D., Rosenshein N B., et al. Endo-metrial cancer and estrogen use. New Engl J Med 1979; 300: 9–13
   PubMed Web of Science ®Google Scholar
• Englund D E., Johansson E DB. Plasma levels of oestrone, oestradiol and gonadotrophins in postmeno-pausal women after oral and vaginal administration of conjugated equine oestrogens (Premarin). Br J Obstet Gynaecol 1978; 85: 959–964
   Google Scholar
• Greenblatt R G. Estrogen therapy for postmenopausal females. New Engl J Med 1965; 272: 305–308
   PubMed Web of Science ®Google Scholar
• Hotchkiss J, Atkinson L E., Knobil E. Time course of serum estrogen and luteinizing hormone (LH) concentrations during the menstrual cycle of the Rhesus monkey. Endoc 1971; 89: 177–183
   PubMed Web of Science ®Google Scholar
• Jick H, Watkin R N., Hunter J R., et al. Replacement oestrogens and endometrial cancer. New Eng J Med 1979; 333: 218–222
   Google Scholar
• Larsson-Cohn U, Johansson E DB, Kagedal B, Wallen-Tin L. Serum FSH, LH and oestrone levels in postmenopausal patients on oestrogen levels in postmenopausal patients on oestrogen therapy. Brit J Obstet Gynaecol 1977; 85: 357–372
   Google Scholar
• Lind T, Cameron E HD, Hunter W M. Serum prolactin, gonadotrophin and oestrogen levels in women receiving hormone replacement therapy. Br J Obstet Gynaecol 1978; 85: 138–141
   Google Scholar
• Longcope C, Tait J R. Validity of metabolic clearance and interconversion rates of estrone and 17β-oestradiol in normal adults. J Clin Endoc 1971; 32: 481
   PubMed Web of Science ®Google Scholar
• Longcope C. Metabolic clearance and blood production rates of estrogens in postmenopausal women. Am J Obstet Gynecol 1971; 111: 778
   PubMed Web of Science ®Google Scholar
• Mack T M., Pike M C., Henderson B E., et al. Estrogens and endometrial cancer in a retirement community. New Engl J Med 1976; 294: 1262–67
   PubMed Web of Science ®Google Scholar
• McDonald T W., Annegers J F., O'Fallon W M., et al. Exogenous estrogen and endometrial carcinoma. Case control and incidence study. Am J Obstet Gynecol 1977; 127: 572–80
   PubMed Web of Science ®Google Scholar
• Rader M D., Flickinger G L., de Villa G O., Jr, et al. Plasma estrogens in postmenopausal women. Am J Obstet Gynecol 1953; 116: 1069
   Google Scholar
• Ryan K J., Engel L L. Interconversion of estrone and es-tradiol by human tissue slices. Endoc 1953; 52: 287
   PubMed Web of Science ®Google Scholar
• Salmon U J., Geist S H., Walter Rl. Treatment of the menopause. Evaluation of estrogen implantation. J Am Med Ass 1941; 117: 1842–1848
   Google Scholar
• Smith D, Prentice R, Thompson D J., et al. Association of exogenous estrogen and endometrial cancer. New Engl J Med 1975; 293: 1164–1167
   PubMed Web of Science ®Google Scholar
• Sommers S C., Meissner W A. Endocrine abnormalities accompanying human endometrial cancer. Cancer 1957; 10: 516–521
   Google Scholar
• Strecker J R., Lauritzen C, Goessens L. Plasma concentrations of conjugated and conjugated estrogens and gonadotrophins following application of various estrogen preparations after oopherectomy and in the menopause. Maturitas 1979; 1: 183–190
   Google Scholar
• Vermeulen A. The hormonal activity of the postmenopausal assay. J Clin Endoc Metab 1976; 42: 247
   PubMed Web of Science ®Google Scholar
• Whittaker P G., Morgan M RA, Dean P DG, et al. Serum equilin, oestrone and oestradiol levels in postmenopausal women receiving conjugated equine oestrogens (Premarin). Lancet 1980; i: 14–16
   Google Scholar
• Wide L, Nillius S J., Genzell C, Roose P. Radioimmuno-sorbent assay of follicle-stimulating hormone and lutei-nizing hormone in serum and urine from men and women. Acta Endoc 1973, Suppl. 174: 3–58
   Google Scholar
• Yen S SC, Martin P L., Burnier A M. Circulating estra-diol, estrone and gonadotrophin levels following the administration of orally active 17β-estradiol in postmenopausal women. J Clin Endoc & Metab 1975; 40: 518
   PubMed Web of Science ®Google Scholar
• Ziel H K., Finkle W D. Increased risk of endometrial carcinoma among users of conjugated estrogens. New Engl J Med 1975; 294: 1167–70
   Google Scholar